🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Malignant Sarcoma

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma NCT07121946Phase 16 sites📍 Duarte📍 St Louis📍 Buffalo LTZ Therapeutics, Inc. · Tests: LTZ-301, LTZ-301, LTZ-301 Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas NCT05952310NA1 site📍 Madrid Antonio Pérez Martínez · Tests: Natural Killer (NK) cells (a new immunotherapy) Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites📍 Denver📍 Atlanta📍 Fairway Verismo Therapeutics · Tests: SynKIR-310 Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST) NCT06222203n/a1 site📍 Bethesda National Cancer Institute (NCI) MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) NCT06299553n/a1 site📍 Milan Incyte Biosciences Italy S.r.l Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) NCT07680933Phase 21 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University · Tests: Orelabrutinib combined with standard immunochemotherapy with or without auto-HSCT AZA Combined With RCHOP in P53-mutated DLBCL. NCT06158399Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Azacitidine in combination with R-CHOP Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL NCT07778212NA2 sites📍 Xiamen📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Orelabrutinib Combined with Pola-R-CHP Regimen IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta NCT05950802Phase 11 site📍 Toronto University Health Network, Toronto · Tests: Cyclophosphamide, TLI Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-CAR.GPC3xIL15.21 CAR T cells Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict) NCT06526065n/a1 site📍 Göttingen University Medical Center Goettingen · Tests: no intervention Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program NCT01772771n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Genetic Testing, Medical Chart Review Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases NCT03093909Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab+liposomal doxorubicin+ifosfamide Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL NCT06151080Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Lenalidomide combined with G-CHOP (LO CHOP) Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes NCT06891157Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Chidamide plus R-CHOP Clinical Applicability of Liquid Biopsy in Chondrosarcoma NCT07492823n/a1 site📍 Graz Medical University of Graz · Tests: laboratory biomarker analysis, Molecular pathology Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors NCT07062003NA1 site📍 Rochester Mayo Clinic · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Medical Device Usage and Evaluation, Minibeam Radiation … A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma NCT06736613Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Cerebral Spinal Fluid ctDNA Molecular Basis of Pediatric Liver Cancer NCT03959800n/a1 site📍 Pittsburgh University of Pittsburgh The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors NCT07459283EARLY Phase 11 site📍 Wuxi FindCure Biosciences (ZhongShan) Co., Ltd. · Tests: INN805 Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762Phase 21 site📍 Hangzhou Zhejiang Provincial People's Hospital · Tests: Mirabegron DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations NCT06988475Phase 2, Phase 317 sites📍 Belfast📍 Birmingham📍 Bristol Cancer Research UK · Tests: Capmatinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy